These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29678261)

  • 21. A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status.
    Gillman PK
    Hum Psychopharmacol; 2006 Mar; 21(2):117-25. PubMed ID: 16342227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.
    Yamamura S; Abe M; Nakagawa M; Ochi S; Ueno S; Okada M
    Neuropharmacology; 2011 Mar; 60(4):550-60. PubMed ID: 21195096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-performance liquid chromatographic assay with fluorescence detection for the routine monitoring of the antidepressant mirtazapine and its demethyl metabolite in human plasma.
    Maris FA; Dingler E; Niehues S
    J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(2):309-16. PubMed ID: 10052704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mirtazapine on sleep polygraphic variables in major depression.
    Schittecatte M; Dumont F; Machowski R; Cornil C; Lavergne F; Wilmotte J
    Neuropsychobiology; 2002; 46(4):197-201. PubMed ID: 12566938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mirtazapine pharmacokinetics with two dosage regimens and two pharmaceutical formulations.
    Timmer CJ; Paanakker JE; Vrijmoed-de Vries M
    Pharm Res; 1997 Jan; 14(1):98-102. PubMed ID: 9034228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of an antidepressant: mirtazapine.
    Preskorn SH
    J Clin Psychiatry; 1997; 58 Suppl 6():3-8. PubMed ID: 9227668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [N-methyl-11C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humans.
    Marthi K; Jakobsen S; Bender D; Hansen SB; Smith SB; Hermansen F; Rosenberg R; Smith DF
    Psychopharmacology (Berl); 2004 Jul; 174(2):260-5. PubMed ID: 14726991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan.
    de Boer TH; Nefkens F; van Helvoirt A; van Delft AM
    J Pharmacol Exp Ther; 1996 May; 277(2):852-60. PubMed ID: 8627567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats.
    Andrzejczak D; Kocon K; Zieba R
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):450-4. PubMed ID: 18699796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of mirtazapine on rat bone tissue after orchidectomy.
    Fekete S; Simko J; Mzik M; Karesova I; Zivna H; Pavlíková L; Palicka V
    Pharmacology; 2015; 95(3-4):166-72. PubMed ID: 25871861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: a pilot study.
    Giorgi M; Yun H
    Vet J; 2012 May; 192(2):239-41. PubMed ID: 21652240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tachyphylaxis to the Sedative Action of Mirtazapine.
    Papazisis G; Siafis S; Tzachanis D
    Am J Case Rep; 2018 Apr; 19():410-412. PubMed ID: 29626184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No influence of dialysis on mirtazapine - a case report.
    Schlotterbeck PM; Vehren T; Milenovic S; Hiemke C; Kircher T; Leube D
    Pharmacopsychiatry; 2008 Nov; 41(6):259-60. PubMed ID: 19067265
    [No Abstract]   [Full Text] [Related]  

  • 36. Mirtazapine for treatment of depression and comorbidities in Alzheimer disease.
    Raji MA; Brady SR
    Ann Pharmacother; 2001 Sep; 35(9):1024-7. PubMed ID: 11573849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study.
    Hundley JL; Yosipovitch G
    J Am Acad Dermatol; 2004 Jun; 50(6):889-91. PubMed ID: 15153889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of mirtazapine and lithium in healthy male subjects.
    Sitsen JM; Voortman G; Timmer CJ
    J Psychopharmacol; 2000 Jun; 14(2):172-6. PubMed ID: 10890312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic drug monitoring of mirtazapine, desmethylmirtazapine, 8-hydroxymirtazapine, and mirtazapine-N-oxide by enantioselective HPLC with fluorescence detection.
    Meineke I; Steinmetz H; Kirchheiner J; Brockmöller J
    Ther Drug Monit; 2006 Dec; 28(6):760-5. PubMed ID: 17164691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of mirtazapine on salivary cortisol in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.